BEDFORD, Mass., March 10 Toxikon Corporation, a preclinical contract testing lab, invites quality assurance, research and development and regulatory professionals to Bedford, Massachusetts April 20 for an international symposium on extractables and leachables testing.
The increased use of disposable components in both manufacturing and packaging materials brings extractables and leachables to the forefront of required testing set forth by governing bodies. As such, Toxikon has seen a surge in demand for this type of testing to qualify the integrity of everything from single use systems to container closures, said Program Coordinator John Iannone.
The seminar will provide tips on how to design an extractables and leachables study and reveal winning strategies for quality control, risk assessment and material selection.
Speakers include Dr. Stephen Doherty, Study Director for Chemistry; Dr. Piet Christiaens, Scientific Director for Chemistry at Toxikon Europe N.V. and Dr. Christopher Brynczka, Study Director for In Vivo Services. An interactive workshop will follow the presentations.
The full day conference is $249 per person and includes the cost of breakfast, lunch and refreshments. Registration is on a first-come, first-served basis and will be limited to 40 people.
A complete agenda can be viewed online at www.toxikon.com, under the "What's New" section.
Toxikon Corporation is an ISO 17025-certified global Contract Research Organization (CRO) that conducts compliance and safety testing for the medical device and biopharmaceutical industries. With more than 30 years of experience, Toxikon provides testing services to meet FDA/ISO/ICH, OECD, USP and Japan's MHLW standards. Testing services include in-vivo toxicology, genetic toxicology, microbiology, and specialized analytical chemistry to meet GMP/GLP requirements.
Toxikon operates a 125,000 square foot facility at their headquarters in Bedford, Massachusetts and has additional locations in the U.S., Europe and Asia.
SOURCE Toxikon Corporation